Your session is about to expire
← Back to Search
Genetic Testing for Increased Risk Breast Cancer
N/A
Waitlist Available
Led By N. Jewel Samadder, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
Study Summary
This trial is looking into how often genetic mutations that increase breast cancer risk occur in women who are at an increased risk for the disease, in order to better inform screening and preventative options.
Eligible Conditions
- Increased Risk Breast Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Genetic mutations
Study Participants
Trial Design
1Treatment groups
Experimental Treatment
Group I: Women at intermediate/high risk of breast cancerExperimental Treatment1 Intervention
Women age 35 years old identified at intermediate/high risk of breast cancer will receive genetic testing
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Genetic Testing
2021
Completed Phase 1
~1510
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,207 Previous Clinical Trials
3,766,744 Total Patients Enrolled
N. Jewel Samadder, MDPrincipal InvestigatorMayo Clinic
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger